Researchers: Whole-genome sequencing does not significantly increase downstream care costs in 200-person Brigham and Women's Hospital study
from DARK Daily
Clinical laboratory testing and personalized medicine continue to reshape how the healthcare industry approaches treating disease. And, whole-genome sequencing has shown promise in helping in vitro diagnostic companies develop specific treatments for specific patients' needs based on their existing conditions and physiology.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063